2 recruiting, 1 active not recruiting, 1 completed, 1 not yet recruiting. 5 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 2, Active not recruiting 1, Completed 1, Not yet recruiting 1 |
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow this drug Literature Review of N-dihydrogalactochitosan trials Research Report on N-dihydrogalactochitosan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases 1.0% IP-001 for Injection, a 10 mg/mL solution of IP-001 in water, 1.0% IP-001 for Injection, a 1 mg/mL solution of IP-001 in water., Microwave (thermal) tumor ablation - Colorectal Cancer (CRC), Colon Cancer Liver Metastases | Phase 2 / Phase 3 | Not yet recruiting | Immunophotonics, Inc. | 717 | 2026-05-01 | 2026-01-07 |
| Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone 1.0% IP-001 for injection, Surgical Resection and Local Ablation, Local Ablation Alone - Hepatocellular Carcinoma | Phase 2 | Recruiting | Robert C. Martin | 315 | 2024-07-24 | 2026-09-04 |
| Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM IP-001 - Colorectal Cancer, Liver Metastases | Phase 1 / Phase 2 | Recruiting | M.R. Meijerink | 120 | 2024-07-10 | 2025-07-03 |
| Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS 1.0% IP-001 for Injection - Metastatic Solid Tumor, Colon Cancer | Phase 1 / Phase 2 | Active not recruiting | Immunophotonics, Inc. | 42 | 2022-11-29 | 2025-01-08 |
| Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. IP-001, Thermal Ablation - Advanced Solid Tumors | Phase 1 / Phase 2 | Completed | Swiss Cancer Institute | 28 | 2020-10-12 | 2025-12-30 |
Colorectal Neoplasms (2) · Melanoma (2) · Neoplasm Metastasis (2) · Neoplasms (2) · Sarcoma (2) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Rectal Neoplasms (1)
Immunophotonics, Inc. (2) · M.R. Meijerink (1) · Robert C. Martin (1) · Swiss Cancer Institute (1)
Switzerland (2) · United States (2) · France (1) · Germany (1) · Netherlands (1) · United Kingdom (1)
Diane Beatty, PhD (1) · Diane M Beatty, PhD (1) · Markus Joerger, MD PhD (1) · Markus Jorger, MD (1) · Martijn R. Meijerink, Prof. (1) · Robert CG Martin, MD, PhD (1)
2023 (1), 2025 (1)